Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

2.

Recent trends in cardiovascular complications among men and women with and without diabetes.

Booth GL, Kapral MK, Fung K, Tu JV.

Diabetes Care. 2006 Jan;29(1):32-7.

PMID:
16373892
3.

Changes in all-cause and cardiovascular disease mortality in three different Finnish population cohorts with and without diabetes.

Barengo NC, Antikainen R, Peltonen M, Tuomilehto J.

Int J Cardiol. 2013 Oct 12;168(5):4734-8. doi: 10.1016/j.ijcard.2013.07.224. Epub 2013 Jul 30.

PMID:
23962774
4.

Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.

Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F.

Lipids Health Dis. 2010 Jan 23;9:6. doi: 10.1186/1476-511X-9-6.

5.
6.

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM.

Diabetes Care. 2006 Apr;29(4):798-804.

PMID:
16567818
7.

Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.

Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB.

Diabetes Care. 2006 Feb;29(2):391-7.

PMID:
16443893
8.

The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study.

Eriksson M, Carlberg B, Eliasson M.

Cerebrovasc Dis. 2012;34(2):153-60. doi: 10.1159/000339763. Epub 2012 Aug 17.

PMID:
22907276
9.

Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.

Ko GT, Chan JC, Chow CC, Yeung VT, Chan WB, So WY, Ma RC, Ozaki R, Cockram CS.

Acta Diabetol. 2003 Jun;40(2):80-4.

PMID:
12861405
10.

Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.

Creagh D, Neilson S, Collins A, Colwell N, Hinchion R, Drew C, O'Halloran D, Perry IJ.

Ir Med J. 2002 Nov-Dec;95(10):298-301.

PMID:
12542011
11.

Obesity, diabetes, and risk of cardiovascular disease in the elderly.

Wilson PW, Kannel WB.

Am J Geriatr Cardiol. 2002 Mar-Apr;11(2):119-23,125. Review.

PMID:
11872970
12.

Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey.

Lehto HR, Lehto S, Havulinna AS, Jousilahti P, Salomaa V.

Eur J Prev Cardiol. 2012 Oct;19(5):1153-60. doi: 10.1177/1741826711422454. Epub 2011 Sep 2.

PMID:
21890534
13.

Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.

Brownrigg JR, de Lusignan S, McGovern A, Hughes C, Thompson MM, Ray KK, Hinchliffe RJ.

Heart. 2014 Dec;100(23):1837-43. doi: 10.1136/heartjnl-2014-305657. Epub 2014 Aug 5.

PMID:
25095826
14.

Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H.

Cardiovasc Diabetol. 2006 Jul 17;5:15.

15.

Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).

Jung CH, Chung JO, Han K, Ko SH, Ko KS, Park JY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association.

Cardiovasc Diabetol. 2017 Jan 6;16(1):1. doi: 10.1186/s12933-016-0482-6.

16.

Prognostic interactions between cardiovascular risk factors.

Vishram JK.

Dan Med J. 2014 Jul;61(7):B4892. Review.

PMID:
25123126
17.

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.

Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, Heeringa J, Portegies ML, Hofman A, Ikram MA, Hunink MG, Franco OH, Stricker BH, Witteman JC, Roos-Hesselink JW.

BMJ. 2014 Nov 17;349:g5992. doi: 10.1136/bmj.g5992.

18.

Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study.

Siyambalapitiya S, Bulugahapitiya U, Sithole J, Song S, Fernando DJ, Idris I.

Diabetes Care. 2007 Aug;30(8):2025-9. Epub 2007 May 22.

PMID:
17519429
19.
20.

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.

Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.

Supplemental Content

Support Center